A biomimetic upconversion nanoreactors for near-infrared driven H2 release to inhibit tauopathy in Alzheimer's disease therapy
-
Published:2024-12
Issue:
Volume:42
Page:165-177
-
ISSN:2452-199X
-
Container-title:Bioactive Materials
-
language:en
-
Short-container-title:Bioactive Materials
Author:
Zhang QinORCID,
Li Chuanqi,
Yin Bohan,
Yan Jiaxiang,
Gu Yutian,
Huang Yingying,
Chen Jiareng,
Lao Xinyue,
Hao Jianhua,
Yi Changqing,
Zhou Yi,
Cheung James Chung WaiORCID,
Wong Siu Hong DexterORCID,
Yang Mo
Reference56 articles.
1. G. Proceedings of the Meeting of the International Working, A.D. the American Alzheimer's Association on "The Preclinical State of, July, U.S.A. Washington Dc, Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria;Dubois;Alzheimers Dement,2016
2. Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade;Savelieff;Chem. Rev.,2019
3. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks;Palop;Nat. Neurosci.,2010
4. Porphyrinic Metal-Organic Framework PCN-224 Nanoparticles for Near-Infrared-Induced Attenuation of Aggregation and Neurotoxicity of Alzheimer's Amyloid-beta Peptide;Wang;ACS Appl. Mater. Interfaces,2018
5. Near-Infrared Photothermally Enhanced Photo-Oxygenation for Inhibition of Amyloid-beta Aggregation Based on RVG-Conjugated Porphyrinic Metal-Organic Framework and Indocyanine Green Nanoplatform;Wang;Int. J. Mol. Sci.,2022